Cannabinoids and rheumatic diseases – evidence review
As medical use of cannabis becomes more accepted around the world a better understanding of the medical and hazardous effects of this drug is imperative, experts report in Nature Reviews Rheumatology.
“Thus far, preliminary clinical trials have explored the effects of cannabis on rheumatoid arthritis, osteoarthritis and fibromyalgia,” the team explains in their review of the evidence. “Preliminary evidence has also found an association between the cannabinoid system and other rheumatic conditions, including systemic sclerosis and juvenile idiopathic arthritis.”
The potential medicinal effects of cannabis could be due to its influence on the immune system, as it may have an immunomodulatory effect on various immune cells including T cells, B cells and macrophages. The researchers conclude:
“The available evidence is not yet sufficient to support the recommendation of cannabinoid treatment for rheumatic diseases.”
NB The next issue of Arthritis Digest Magazine discusses the situation in the UK in greater depth; subscribe now so you don’t miss out.
Arthritis Digest Magazine was selected by Feedspot as one of the Top 5 Arthritis Blogs on the internet in 2018.
For more in-depth features, interviews and information, subscribe to Arthritis Digest magazine, a popular title that’s published six times a year. Click here for the digital version or tel 0845 643 8470 to order your had copy. You’ll know what your doctor is talking about, what new drugs are in the pipeline and be up to date on helpful products.